• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米颗粒内皮递送 PGC-1α 通过减轻 EndoMT 引起的血管壁重构来减轻低氧诱导的肺动脉高压。

Nanoparticle endothelial delivery of PGC-1α attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling.

机构信息

Departments of Surgery, University of Missouri School of Medicine, Columbia, MO, USA.

Departments of Surgery, University of Missouri School of Medicine, Columbia, MO, USA; Department of Medical Pharmacology & Physiology, University of Missouri School of Medicine, Columbia, MO, USA.

出版信息

Redox Biol. 2022 Dec;58:102524. doi: 10.1016/j.redox.2022.102524. Epub 2022 Oct 28.

DOI:10.1016/j.redox.2022.102524
PMID:36334380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9637961/
Abstract

Pulmonary hypertension (PH) induced by chronic hypoxia is characterized by thickening of pulmonary artery walls, elevated pulmonary vascular resistance, and right-heart failure. Dysfunction of endothelial cells is the hallmark event in the progression of PH. Among various mechanisms, endothelial to mesenchymal transition (EndoMT) has emerged as an important source of endothelial cell dysfunction in PH. However, the mechanisms underlying the EndoMT in PH remain largely unknown. Our results showed that peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) expression was decreased in pulmonary arterial endothelial cells (PAECs) in PH patients and hypoxia-induced PH mouse model compared to the normal controls. Endothelial-specific overexpression of PGC-1α using nanoparticle delivery significantly attenuated the progression of PH, as shown by the significantly decreased right ventricular systolic pressure and diminished artery thickness as well as reduced vascular muscularization. Moreover, Endothelial-specific overexpression of PGC-1α blocked the EndoMT of PAECs during PH, indicating that loss of PGC-1α promotes PH development by mediating EndoMT, which damages the integrity of endothelium. Intriguingly, we found that PGC-1α overexpression rescued the expression of endothelial nitric oxide synthase in mouse lung tissues that was deceased by hypoxia treatment in vivo and in endothelial cells treated with TGF-β in vitro. Consistently, PAECs and vascular smooth muscle co-culture showed that overexpression of PGC-1α in PAECs increases nitric oxide release, which would likely diffuse to smooth muscle cells, where it activates specific protein kinases, and initiates SMC relaxation by diminishing the calcium flux. Endothelial-specific overexpression of PGC-1α also attenuated hypoxia-induced pulmonary artery stiffness which appeared to be caused by both the decreased endothelial nitric oxide production and increased vascular remodeling. Taken together, these results demonstrated that endothelial-specific delivery of PGC-1α prevents PH development by inhibiting EndoMT of PAECs and thus restoring endothelial function and reducing vascular remodeling.

摘要

慢性缺氧引起的肺动脉高压(PH)的特征是肺血管壁增厚、肺血管阻力升高和右心衰竭。内皮细胞功能障碍是 PH 进展的标志性事件。在各种机制中,内皮向间充质转化(EndoMT)已成为 PH 中内皮细胞功能障碍的重要来源。然而,PH 中 EndoMT 的机制在很大程度上仍然未知。我们的结果表明,与正常对照组相比,PH 患者和缺氧诱导的 PH 小鼠模型中的肺动脉内皮细胞(PAEC)中过氧化物酶体增殖物激活受体γ共激活因子 1-α(PGC-1α)的表达降低。通过纳米颗粒递送在内皮细胞中特异性过表达 PGC-1α 可显著减轻 PH 的进展,表现为右心室收缩压显著降低,动脉厚度减小以及血管肌化减少。此外,内皮细胞特异性过表达 PGC-1α 可阻断 PH 期间的 PAEC 发生 EndoMT,表明 PGC-1α 的缺失通过介导 EndoMT 促进 PH 的发展,从而破坏内皮的完整性。有趣的是,我们发现 PGC-1α 过表达可恢复体内缺氧处理和体外 TGF-β处理的内皮细胞中表达的内皮型一氧化氮合酶。一致地,PAEC 和血管平滑肌共培养显示,PAEC 中 PGC-1α 的过表达增加了一氧化氮的释放,一氧化氮可能扩散到平滑肌细胞,在平滑肌细胞中,它通过减少钙流来激活特定的蛋白激酶,并启动 SMC 松弛。内皮细胞特异性过表达 PGC-1α 还可减轻缺氧诱导的肺动脉僵硬,这似乎是由于内皮一氧化氮产生减少和血管重塑增加所致。总之,这些结果表明,内皮细胞特异性递送 PGC-1α 通过抑制 PAEC 的 EndoMT 来预防 PH 的发展,从而恢复内皮功能并减少血管重塑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/81ff653fc220/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/ea3e951ce79c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/5754b8e865d0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/7844b7871ebe/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/e1aeb75c082f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/d03c0e0ec038/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/7d7632e7ef8a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/08f55044d42d/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/f215896ed74c/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/81ff653fc220/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/ea3e951ce79c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/5754b8e865d0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/7844b7871ebe/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/e1aeb75c082f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/d03c0e0ec038/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/7d7632e7ef8a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/08f55044d42d/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/f215896ed74c/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91c2/9637961/81ff653fc220/gr8.jpg

相似文献

1
Nanoparticle endothelial delivery of PGC-1α attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling.纳米颗粒内皮递送 PGC-1α 通过减轻 EndoMT 引起的血管壁重构来减轻低氧诱导的肺动脉高压。
Redox Biol. 2022 Dec;58:102524. doi: 10.1016/j.redox.2022.102524. Epub 2022 Oct 28.
2
Suppression of endothelial PGC-1α is associated with hypoxia-induced endothelial dysfunction and provides a new therapeutic target in pulmonary arterial hypertension.内皮细胞中PGC-1α的抑制与缺氧诱导的内皮功能障碍相关,并为肺动脉高压提供了一个新的治疗靶点。
Am J Physiol Lung Cell Mol Physiol. 2016 Jun 1;310(11):L1233-42. doi: 10.1152/ajplung.00356.2015. Epub 2016 Apr 15.
3
PGC-1α overexpression suppresses blood pressure elevation in DOCA-salt hypertensive mice.过氧化物酶体增殖物激活受体γ共激活因子1α(PGC-1α)过表达可抑制去氧皮质酮盐(DOCA-盐)高血压小鼠的血压升高。
Biosci Rep. 2015 May 21;35(3):e00217. doi: 10.1042/BSR20150076.
4
Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension.内皮向间充质转化促成肺动脉高压中的内皮功能障碍。
Am J Pathol. 2015 Jul;185(7):1850-8. doi: 10.1016/j.ajpath.2015.03.019. Epub 2015 May 5.
5
PPARγ/ETV2 axis regulates endothelial-to-mesenchymal transition in pulmonary hypertension.PPARγ/ETV2轴调控肺动脉高压中的内皮-间充质转化。
Pulm Circ. 2024 Oct 10;14(4):e12448. doi: 10.1002/pul2.12448. eCollection 2024 Oct.
6
The role of PDGF-B/TGF-β1/neprilysin network in regulating endothelial-to-mesenchymal transition in pulmonary artery remodeling.血小板衍生生长因子-B/转化生长因子-β1/中性内肽酶网络在肺动脉重塑中调节内皮-间充质转化的作用。
Cell Signal. 2016 Oct;28(10):1489-501. doi: 10.1016/j.cellsig.2016.06.022. Epub 2016 Jun 30.
7
Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension.内皮细胞异质性在自噬反应中的作用驱动肺动脉高压中小血管的肌化。
Circulation. 2024 Aug 6;150(6):466-487. doi: 10.1161/CIRCULATIONAHA.124.068726. Epub 2024 Jun 14.
8
Overexpressed pigment epithelium-derived factor alleviates pulmonary hypertension in two rat models induced by monocrotaline and SU5416/hypoxia.过表达的色素上皮衍生因子可减轻由野百合碱和SU5416/低氧诱导的两种大鼠模型中的肺动脉高压。
Biomed Pharmacother. 2024 Mar;172:116303. doi: 10.1016/j.biopha.2024.116303. Epub 2024 Feb 20.
9
Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.过氧化物酶体增殖物激活受体γ与微小RNA 98在缺氧诱导的内皮素-1信号传导中的作用
Am J Respir Cell Mol Biol. 2016 Jan;54(1):136-46. doi: 10.1165/rcmb.2014-0337OC.
10
Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.LR11缺失可减轻小鼠缺氧诱导的肺动脉平滑肌细胞增殖并伴有中膜增厚。
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1972-9. doi: 10.1161/ATVBAHA.116.307900. Epub 2016 Aug 4.

引用本文的文献

1
Interaction of ferroptosis and cuproptosis in the perspective of pulmonary hypertension.从肺动脉高压角度看铁死亡与铜死亡的相互作用
Front Cardiovasc Med. 2025 Jun 26;12:1611449. doi: 10.3389/fcvm.2025.1611449. eCollection 2025.
2
Mucosal boosting increases protective efficacy of an influenza vaccine in mice.黏膜加强免疫可提高流感疫苗对小鼠的保护效力。
iScience. 2025 May 21;28(6):112721. doi: 10.1016/j.isci.2025.112721. eCollection 2025 Jun 20.
3
Skeletal muscle endothelial dysfunction through the activin A-PGC1α axis drives progression of cancer cachexia.
通过激活素A-过氧化物酶体增殖物激活受体γ辅激活因子1α轴介导的骨骼肌内皮功能障碍推动癌症恶病质进展。
Nat Cancer. 2025 May 26. doi: 10.1038/s43018-025-00975-6.
4
Fibronectin Mediates Endothelial-to-Mesenchymal Transition in Retina Angiogenesis.纤连蛋白介导视网膜血管生成中的内皮-间充质转化。
Invest Ophthalmol Vis Sci. 2025 Mar 3;66(3):10. doi: 10.1167/iovs.66.3.10.
5
Role of hyperhomocysteinemia in atherosclerosis: from bench to bedside.高同型半胱氨酸血症在动脉粥样硬化中的作用:从实验台到临床
Ann Med. 2025 Dec;57(1):2457527. doi: 10.1080/07853890.2025.2457527. Epub 2025 Feb 3.
6
PKM2-Driven Lactate Overproduction Triggers Endothelial-To-Mesenchymal Transition in Ischemic Flap via Mediating TWIST1 Lactylation.PKM2驱动的乳酸过度产生通过介导TWIST1乳酸化触发缺血皮瓣中的内皮-间充质转化。
Adv Sci (Weinh). 2024 Dec;11(47):e2406184. doi: 10.1002/advs.202406184. Epub 2024 Oct 30.
7
Mechanisms of lung endothelial cell injury and survival in pulmonary arterial hypertension.肺动脉高压中肺内皮细胞损伤与存活的机制
Am J Physiol Lung Cell Mol Physiol. 2024 Dec 1;327(6):L972-L983. doi: 10.1152/ajplung.00208.2024. Epub 2024 Oct 15.
8
Endothelial Foxo1 Phosphorylation Inhibition via Aptamer-Liposome Alleviates OPN-Induced Pathological Vascular Remodeling Following Spinal Cord Injury.通过适体脂质体抑制内皮细胞 Foxo1 的磷酸化可减轻脊髓损伤后 OPN 诱导的病理性血管重塑。
Adv Sci (Weinh). 2024 Nov;11(43):e2406398. doi: 10.1002/advs.202406398. Epub 2024 Sep 28.
9
Urolithin A Protects against Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Smooth Muscle Cell Pyroptosis via AMPK/NF-κB/NLRP3 Signaling.尿石素 A 通过 AMPK/NF-κB/NLRP3 信号通路抑制肺动脉平滑肌细胞焦亡来防治低氧性肺动脉高压。
Int J Mol Sci. 2024 Jul 28;25(15):8246. doi: 10.3390/ijms25158246.
10
Reactive oxygen species in hypertension.高血压中的活性氧物种
Nat Rev Cardiol. 2025 Jan;22(1):20-37. doi: 10.1038/s41569-024-01062-6. Epub 2024 Jul 24.